{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:09:39Z","timestamp":1791295779189,"version":"4.1.0"},"reference-count":26,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,10,15]]},"abstract":"<jats:p>Acute promyelocytic leukemia (APL) is associated with chromosomal translocations resulting in fusion proteins of the retinoic acid receptor (RAR). Here, we report a novel murine model system for APL, based on the transduction of purified murine hematopoietic progenitors (lin\u2212) using high-titer retroviral vectors encoding promyelocytic leukemia\u2013RAR (PML-RAR), and the green fluorescent protein (GFP) as a marker. PML-RAR\u2013expressing lin\u2212 cells were impaired in their ability to undergo terminal myeloid differentiation and showed increased proliferative potential in vitro. Inoculation of transduced lin\u2212 cells into syngeneic, irradiated mice resulted in the development of retinoic acid-sensitive promyelocytic leukemias at high frequency (&gt; 80%) and short latency (approximately 4 months). Morphologic and immunophenotypic analysis revealed no gross abnormalities of the preleukemic bone marrows. However, hematopoietic progenitors from PML-RAR preleukemic mice showed a severe impairment in their ability to undergo myeloid differentiation in vitro. This result, together with the monoclonality or oligoclonality of the leukemic blasts, supports a \u201cmultiple-hit\u201d model, where the fusion protein causes a \u201cpreleukemic\u201d phase, and leukemia occurs after additional genetic lesions. This model system faithfully reproduces the main characteristics of human APL and represents a versatile tool for the in vitro and in vivo study of mechanisms of leukemogenesis and the design of protocols for differentiation treatment.<\/jats:p>","DOI":"10.1182\/blood-2001-11-0089","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T19:44:31Z","timestamp":1033069471000},"page":"2989-2995","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":87,"title":["PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors"],"prefix":"10.1182","volume":"100","author":[{"given":"Saverio","family":"Minucci","sequence":"first","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Monestiroli","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Giavara","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ronzoni","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marchesi","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Insinga","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Diverio","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Gasparini","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Capillo","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Colombo","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Matteucci","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Contegno","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lo-Coco","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Scanziani","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gobbi","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giuseppe","family":"Pelicci","sequence":"additional","affiliation":[{"name":"From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome \u201cLa Sapienza,\u201d Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111823445981200_B1","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood.V93.10.3167.410k44_3167_3215","article-title":"Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.","volume":"93","author":"Melnick","year":"1999","journal-title":"Blood."},{"key":"2019111823445981200_B2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0037-1963(01)90002-2","article-title":"All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.","volume":"38","author":"Fenaux","year":"2001","journal-title":"Semin Hematol."},{"key":"2019111823445981200_B3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJM199307153290307","article-title":"Acute promyelocytic leukemia.","volume":"329","author":"Warrell","year":"1993","journal-title":"N Engl J Med."},{"key":"2019111823445981200_B4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0092-8674(93)80044-F","article-title":"The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells.","volume":"74","author":"Grignani","year":"1993","journal-title":"Cell."},{"key":"2019111823445981200_B5","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/j.1460-2075.1996.tb00631.x","article-title":"A retrovirus carrying the promyelocyte-retinoic acid receptor PML- RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias.","volume":"15","author":"Altabef","year":"1996","journal-title":"EMBO J."},{"key":"2019111823445981200_B6","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.94.6.2551","article-title":"A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.","volume":"94","author":"Brown","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111823445981200_B7","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1073\/pnas.93.15.7900","article-title":"Transgenic expression of PML\/RARalpha impairs myelopoiesis.","volume":"93","author":"Early","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111823445981200_B8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood.V89.2.376","article-title":"Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.","volume":"89","author":"Grisolano","year":"1997","journal-title":"Blood."},{"key":"2019111823445981200_B9","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1073\/pnas.94.10.5302","article-title":"Acute leukemia with promyelocytic features in PML\/RARalpha transgenic mice.","volume":"94","author":"He","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111823445981200_B10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1182\/blood.V95.5.1541.005k28_1541_1550","article-title":"Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable.","volume":"95","author":"Kogan","year":"2000","journal-title":"Blood."},{"key":"2019111823445981200_B11","first-page":"544","article-title":"Retroviral vectors for the transduction of the PML-RARalpha fusion product of acute promyelocytic leukemia.","volume":"24","author":"Lavau","year":"1996","journal-title":"Exp Hematol."},{"key":"2019111823445981200_B12","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1038\/sj.onc.1204600","article-title":"In vivo analysis of the molecular genetics of acute promyelocytic leukemia.","volume":"20","author":"Pandolfi","year":"2001","journal-title":"Oncogene."},{"key":"2019111823445981200_B13","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood.V93.7.2143","article-title":"Seed versus soil: the importance of the target cell for transgenic models of human leukemias [see comments].","volume":"93","author":"Westervelt","year":"1999","journal-title":"Blood."},{"key":"2019111823445981200_B14","first-page":"14","article-title":"High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV\/retroviral vector expressing the green fluorescence protein.","volume":"58","author":"Grignani","year":"1998","journal-title":"Cancer Res."},{"key":"2019111823445981200_B15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1097-2765(00)80321-4","article-title":"Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.","volume":"5","author":"Minucci","year":"2000","journal-title":"Mol Cell."},{"key":"2019111823445981200_B16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1182\/blood.V94.2.793","article-title":"Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.","volume":"94","author":"Du","year":"1999","journal-title":"Blood."},{"key":"2019111823445981200_B17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood.V94.1.12.413a44_12_22","article-title":"Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia.","volume":"94","author":"Lo Coco","year":"1999","journal-title":"Blood."},{"key":"2019111823445981200_B18","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V85.7.1871.bloodjournal8571871","article-title":"Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia.","volume":"85","author":"Flenghi","year":"1995","journal-title":"Blood."},{"key":"2019111823445981200_B19","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1182\/blood.V99.8.2985","article-title":"Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.","volume":"99","author":"Le Beau","year":"2002","journal-title":"Blood."},{"key":"2019111823445981200_B20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2141.1999.01296.x","article-title":"A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia.","volume":"105","author":"Specchia","year":"1999","journal-title":"Br J Haematol."},{"key":"2019111823445981200_B21","first-page":"781","article-title":"Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids.","volume":"10","author":"Angulo","year":"1996","journal-title":"Mol Endocrinol."},{"key":"2019111823445981200_B22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-8652(199711)56:3<131::AID-AJH1>3.0.CO;2-Z","article-title":"Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants.","volume":"56","author":"Neame","year":"1997","journal-title":"Am J Hematol."},{"key":"2019111823445981200_B23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ajh.1073","article-title":"CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular\/hypogranular morphology, expression of CD2 and bcr3 isoform.","volume":"67","author":"Foley","year":"2001","journal-title":"Am J Hematol."},{"key":"2019111823445981200_B24","doi-asserted-by":"crossref","first-page":"15103","DOI":"10.1073\/pnas.96.26.15103","article-title":"A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.","volume":"96","author":"Pollock","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111823445981200_B25","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.97.24.13306","article-title":"Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.","volume":"97","author":"Zimonjic","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111823445981200_B26","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1038\/sj.onc.1204336","article-title":"Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?","volume":"20","author":"Minucci","year":"2001","journal-title":"Oncogene."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/8\/2989\/1258260\/h82002002989.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/8\/2989\/1258260\/h82002002989.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T23:45:12Z","timestamp":1574120712000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/8\/2989\/106431\/PMLRAR-induces-promyelocytic-leukemias-with-high"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,15]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2001-11-0089","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10,15]]}}}